LEGN

Legend Biotech Corporation

65.98 USD
-0.12 (-0.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Legend Biotech Corporation stock is up 16.68% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 3 CALLs, 7 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 16:33 15 Mar, 2024 60.00 CALL 153 107
21 Feb 15:16 19 Apr, 2024 55.00 PUT 75 0
21 Feb 16:33 19 Apr, 2024 55.00 PUT 99 0
21 Feb 17:35 19 Apr, 2024 55.00 PUT 91 0
21 Feb 18:10 19 Apr, 2024 55.00 PUT 79 0
21 Feb 18:10 19 Apr, 2024 55.00 PUT 82 0
21 Feb 18:11 15 Mar, 2024 55.00 PUT 204 300
22 Feb 15:14 19 Apr, 2024 70.00 CALL 234 1
22 Feb 15:47 19 Apr, 2024 55.00 PUT 77 1000
23 Feb 15:24 15 Mar, 2024 65.00 CALL 158 1097

About Legend Biotech Corporation

Legend Biotech Corporation engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for gastric cancer and T cell lymphoma.